Table 4.

Admission Characteristics by Treatment Received and Immune Status: Immunocompromised.

Characteristic	WHEY (n = 13)	ZSGM (n = 14)	P Value
Age, median (range), y	8.6 (1–18)	6.7 (1–18)	.32a
Female, %	46	43	.86b
Weight-for-age percentile, median (range)	22 (0–100)	11 (0–86)	.23a
	n = 13	n = 13
Height-for-age percentile, median (range)	9 (0–100)	1 (0–39)	.36a
BMI-for-age percentile, median (range)	74 (0–99)	41 (0–100)	.18a
PELOD, median (range)	11 (1–31)	12 (0–22)	.96a
PRISM, median (range)	12 (3–17)	12 (0–26)	.98a
OFI, median (range)	2(1–3)	2 (0–4)	.72a
Postoperative PICU admit, %	31	7	.16c
Primary diagnosis, %			.84c
Cancer	31	14
Cardiac arrest	8	0
Cardiovascular disease—acquired	8	0
Cardiovascular disease—congenital	8	7
HIV infection	0	7
Pneumonia/bronchiolitis	8	14
Sepsis	8	21
Shock	0	7
Transplant	8	0
Other	23	29
Chronic diagnoses, %	69	79	.68c
Infection status at entry, %			.68c
Existing infection	38	57
Existing sepsis	38	29
No infection or sepsis	23	14

BMI, body mass index; HIV, human immunodeficiency virus; OFI, Organ Failure Index; PELOD, Pediatric Logistic Organ Dysfunction score; PICU, pediatric intensive care unit; PRISM, Pediatric Risk of Mortality; WHEY, whey protein powder and intravenous saline group; ZSGM, zinc, selenium, glutamine, and metoclopramide group.

^aP value is based on the Wilcoxon rank-sum test for continuous/ordinal characteristics.

^bP value is based on the Pearson χ² test for categorical characteristics.

^cP value is based on the Fisher exact test for categorical characteristics.